A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

A woman who thought she was experiencing symptoms of the menopause actually went on to be diagnosed with womb cancer and now wants to warn other women to get checked if they notice anything unusual.

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

To identify the genes jointly identified by both analysis methods, we plotted a Wayne diagram (Figure 2D ... in obtaining tumor tissue samples post-radiotherapy for endometrial cancer due to various ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...